You searched for "outcome"
Infliximab in treatment of PVR
In this phase 2 randomly controlled trial, 66 patients with primary rhegmatogenous retinal detachment and grade C proliferative vitreoretinopathy (PVR) were randomised in a 1:1 ratio to undergo pars plana vitrectomy (PPV) and silicone oil (SO) injection with or without...
Efficacy of augmented-dosed surgery versus botulinum toxin A injection for acute acquired concomitant esotropia
This is a retrospective study of 104 patients diagnosed with acute acquired concomitant esotropia (AACE) between 2020 and 2022. Potential factors that influence the dose-response of bilateral medial rectus recession (MRec) and the rate and risk factors for ACCE relapse...
Systematic review of management options for intermittent exotropia
The authors conduct a robust systematic review of the literature to report evidence on non-surgical and surgical treatment options for intermittent exotropia – divergence excess and basic intermittent exotropia types. Discussion centres on (1) optical correction of refractive error with...
FSAK versus toric IOL implantation for correcting astigmatism in cataract patients
Nine studies of 590 patients were retrieved from the Ovid-Medline, EMBASE, Cochrane register of controlled trials and Scopus which compared femtosecond laser-assisted astigmatic keratotomy (FSAK) and toric IOL for astigmatism correction in cataract patients. The trial sequential analysis was used...
Augmented surgery with BTA for large angle strabismus correction
This retrospective study reports the results of botulinum toxin A (BTA) augmented bilateral recession or monocular recession / resection (RR) for patients with large angle strabismus. Twenty-four patients were recruited: 10 female, mean age 9.2 ±13.6 years, 20 esotropia and...
